Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Market Cap	26.34B
Revenue (ttm)	5.29B
Net Income (ttm)	9.61M
Shares Out	13.86B
EPS (ttm)	0.00
PE Ratio	2,741.56
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,358,941
Average Volume	148,949,165
Open	1.900
Previous Close	1.900
Day's Range	1.900 - 1.920
52-Week Range	1.680 - 2.950
Beta	0.72
RSI	39.49
Earnings Date	Aug 21, 2025

About Kangmei Pharmaceutical

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 4,233
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600518

Financial Performance

In 2024, Kangmei Pharmaceutical's revenue was 5.19 billion, an increase of 6.47% compared to the previous year's 4.87 billion. Earnings were 8.57 million, a decrease of -91.64%.